NCT06002113 Eliciting Informed Goals of Care in Elderly Patients
| NCT ID | NCT06002113 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Royal Victoria Hospital, Canada |
| Condition | Goals of Care |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2023-10-03 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,200 participants in total. It began in 2023-10-03 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Patient-centered medical care considers a patient's values and goals for their health and well-being. Healthcare providers use this information to formulate a medical care plan that is aligned with these expectations. This shared-decision making process should occur with every medical decision, but it is especially important whenever decisions about end-of-life care are being considered. Eliciting patient preferences about resuscitation and life-support treatments in the event of life-threatening illnesses are considered to be a standard of excellent and appropriate medical care. Unfortunately, these discussions don't happen consistently and even when they do occur, are rarely ideal. The consequences can be devastating, often resulting in the delivery of unwanted medical care that can be associated with significant physical and mental suffering among patients and their families. In response to this problem, the investigators developed a novel tool to help guide these difficult conversations between healthcare providers and patients. The investigators previously tested this tool in a small group of hospitalized patients who found it acceptable and helpful. In this larger study, the investigators will compare how effective this tool is compared to usual care in ensuring hospitalized patients have their treatment preferences identified, documented and result in end-of-life care that is consistent with their preferences.
Eligibility Criteria
Inclusion Criteria: * Hospitalized patients ≥ 80 years old with an acute medical or surgical condition admitted to any hospital ward * Previously or currently documented CODE STATUS preferences include any life sustaining therapies * Duration of admission ≥ 24 hours * English speaking, or translator present * Competent patient or substitute decision maker Exclusion Criteria: * Treating physician, patient, or substitute decision maker declines * Documented resuscitation preferences for comfort or supportive care * New diagnosis of life-limiting illness on this hospital admission, for example, new diagnosis of metastatic cancer * Clinically unstable, admitted to an intensive care unit, or currently receiving acute life support treatment (mechanical ventilation, acute dialysis, or inotropic/vasopressor support) * Readmission after index hospitalization * Pre-existing need for chronic mechanical ventilation (invasive mechanical ventilation via tracheostomy \> 90 days) or maintenance dialysis (peritoneal or hemodialysis \> 90 days)
Contact & Investigator
Giulio DiDiodato, MD PhD
PRINCIPAL INVESTIGATOR
Royal Victoria Regional Health Centre
Frequently Asked Questions
Who can join the NCT06002113 clinical trial?
This trial is open to participants of all sexes, aged 80 Years or older, studying Goals of Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06002113 currently recruiting?
Yes, NCT06002113 is actively recruiting participants. Contact the research team at didiodatog@rvh.on.ca for enrollment information.
Where is the NCT06002113 trial being conducted?
This trial is being conducted at Barrie, Canada.
Who is sponsoring the NCT06002113 clinical trial?
NCT06002113 is sponsored by Royal Victoria Hospital, Canada. The principal investigator is Giulio DiDiodato, MD PhD at Royal Victoria Regional Health Centre. The trial plans to enroll 1,200 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.